Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 5MG BASE;EQ 10MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
18
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 2.5MG BASE;EQ 20MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
17
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 10MG BASE;EQ 20MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
16
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 5MG BASE;EQ 80MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
15
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 5MG BASE;EQ 20MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
14
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 2.5MG BASE;EQ 40MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
13
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 10MG BASE;EQ 40MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
12
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 2.5MG BASE;EQ 10MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
11
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Regulatory Information RX
With a dosage strength EQ 10MG BASE;EQ 10MG BASE
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2014-03-07
Therapeutic Equivalence (TE) Code AB
10
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM, with a corresponding application number 203874.
Market Place
KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
